Literature DB >> 17785749

Treatment of benign bone tumours using external fixation.

H Tsuchiya1, A F Morsy, H Matsubara, K Watanabe, M E Abdel-Wanis, K Tomita.   

Abstract

We present a retrospective study of patients suffering from a variety of benign tumours in whom external fixators were used to treat deformity and limb-length discrepancy, and for the reconstruction of bone defects. A total of 43 limbs in 31 patients (12 male and 19 female) with a mean age of 14 years (2 to 54) were treated. The diagnosis was Ollier's disease in 12 limbs, fibrous dysplasia in 11, osteochondroma in eight, giant cell tumour in five, osteofibrous dysplasia in five and non-ossifying fibroma in two. The lesions were treated in the tibia in 19 limbs, in the femur in 16, and in the forearm in eight. The Ilizarov frame was used in 25 limbs, the Taylor Spatial Frame in seven, the Orthofix fixator in six, the Monotube in four and the Heidelberg fixator in one. The mean follow-up was 72 months (22 to 221). The mean external fixation period was 168 days (71 to 352). The mean external fixation index was 42 days/cm (22.2 to 102.0) in the 22 patients who required limb lengthening. The mean correction angle for those with angular deformity was 23 degrees (7 degrees to 45 degrees ). At final follow-up all patients had returned to normal activities. Four patients required a second operation for recurrent deformity of further limb lengthening. Local recurrence occurred in one patient, requiring further surgery.

Entities:  

Mesh:

Year:  2007        PMID: 17785749     DOI: 10.1302/0301-620X.89B8.19132

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  11 in total

1.  Recurrence of a Unicameral Bone Cyst in the Femoral Diaphysis.

Authors:  Hyun Se Kim; Kyung Sup Lim; Sung Wook Seo; Seung Pil Jang; Jong Sup Shim
Journal:  Clin Orthop Surg       Date:  2016-11-04

2.  [Osteofibrous dysplasia campanacci of the tibia. A 12-year follow-up].

Authors:  M Napp; B-A Stengel; J Buschmann; J R Döhler
Journal:  Chirurg       Date:  2009-03       Impact factor: 0.955

Review 3.  Non-ossifying fibroma, fibrous cortical defect and Jaffe-Campanacci syndrome: a biologic and clinical review.

Authors:  Henry J Mankin; Carol A Trahan; Gertrud Fondren; Carole J Mankin
Journal:  Chir Organi Mov       Date:  2009-04-29

4.  Lower limb lengthening and deformity correction in polyostotic fibrous dysplasia using external fixation and flexible intramedullary nailing.

Authors:  Arnold Popkov; Anna Aranovich; Alexander Antonov; Pierre Journeau; Pierre Lascombes; Dmitry Popkov
Journal:  J Orthop       Date:  2020-03-28

5.  Distraction osteogenesis and arthrodesis as a new surgical option for chondrosarcoma in the distal tibia.

Authors:  Zhengxiao Ouyang; Xuezheng Xu; Linqing Li; Yi Luo; Jianfan Liu; Xin Wang; Xinyu Yao; Gang Huang; Xianan Li
Journal:  World J Surg Oncol       Date:  2015-05-22       Impact factor: 2.754

6.  External fixation reconstruction of the residual problems of benign bone tumours.

Authors:  Levent Eralp; F Erkal Bilen; S Robert Rozbruch; Mehmet Kocaoglu; Ahmed I Hammoudi
Journal:  Strategies Trauma Limb Reconstr       Date:  2016-02-12

7.  Effects of Taylor Spatial Frame on tumors and tumor-like lesions with pathological fractures of lower extremities.

Authors:  Zhongbing Liu; Genling Tang; Shuguang Guo; Bin Cai; Qingsong Li
Journal:  Pak J Med Sci       Date:  2018 Mar-Apr       Impact factor: 1.088

8.  Bone Transport for Reconstruction in Benign Bone Tumors.

Authors:  Chang Seon Oh; Sung Taek Jung; Yong Jin Cho; Yeong Seub Ahn; Bo Ram Na
Journal:  Clin Orthop Surg       Date:  2015-05-18

9.  Reconstruction by bone transport after resection of benign tumors of tibia: A retrospective study of 38 patients.

Authors:  Dmitry Y Borzunov; Pavel I Balaev; Koushik N Subramanyam
Journal:  Indian J Orthop       Date:  2015 Sep-Oct       Impact factor: 1.251

10.  Multiple non-ossifying fibromas as a cause of pathological femoral fracture in Jaffe-Campanacci syndrome.

Authors:  Stéphane Cherix; Yann Bildé; Fabio Becce; Igor Letovanec; Hannes A Rüdiger
Journal:  BMC Musculoskelet Disord       Date:  2014-06-26       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.